Sanofi Holds Line On Aventis Merger Price; Novartis Enters Talks

Sanofi will continue to evaluate the market reaction before deciding whether to sweeten its bid. Novartis accepts Aventis’ invitation to explore a deal; the move indicates France has expressed neutrality on an Aventis/Novartis combination.

More from Archive

More from Pink Sheet